Cite
Investigation of RBM10 mutation and its associations with clinical and molecular characteristics in EGFR -mutant and EGFR -wildtype lung adenocarcinoma.
MLA
Cao, Yingyue, et al. “Investigation of RBM10 Mutation and Its Associations with Clinical and Molecular Characteristics in EGFR -Mutant and EGFR -Wildtype Lung Adenocarcinoma.” Heliyon, vol. 10, no. 11, May 2024, p. e32287. EBSCOhost, https://doi.org/10.1016/j.heliyon.2024.e32287.
APA
Cao, Y., Lan, D., Ke, X., Zheng, W., Zeng, J., Niu, N., Fu, C., Deng, W., & Jin, S. (2024). Investigation of RBM10 mutation and its associations with clinical and molecular characteristics in EGFR -mutant and EGFR -wildtype lung adenocarcinoma. Heliyon, 10(11), e32287. https://doi.org/10.1016/j.heliyon.2024.e32287
Chicago
Cao, Yingyue, Dongmei Lan, Xianni Ke, Wenyu Zheng, Jialong Zeng, Niu Niu, Chunmei Fu, Wencui Deng, and Shi Jin. 2024. “Investigation of RBM10 Mutation and Its Associations with Clinical and Molecular Characteristics in EGFR -Mutant and EGFR -Wildtype Lung Adenocarcinoma.” Heliyon 10 (11): e32287. doi:10.1016/j.heliyon.2024.e32287.